Activation of TLR9 signaling in fibroblastic reticular cells enhances anti-tumor immunity in peritoneal tumor via suppressing peritoneal resident macrophage retention

被引：0
|
作者：
Deng, Meihong
机构：
来源：
JOURNAL OF IMMUNOLOGY | 2022年 / 208卷 / 01期
关键词：
D O I：
10.4049/jimmunol.208.Supp.53.19
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
53.19
引用
收藏
页数：2
相关论文
共 50 条
  • [41] TAC-001, a toll-like receptor 9 (TLR9) agonist antibody conjugate targeting B cells, promotes anti-tumor immunity and favorable safety profile following systemic administration in preclinical models.
    Kuo, Tracy C.
    Harrabi, Ons
    Chen, Amy
    Sangalang, Emma R.
    Doyle, Laura
    Fontaine, Danielle
    Li, Min
    Han, Bora
    Pons, Jaume
    Sim, Janet
    Wan, Hong I.
    CANCER RESEARCH, 2021, 81 (13)
  • [42] EGFR-selective activation of CD27 co-stimulatory signaling by a bispecific antibody enhances anti-tumor activity of T cells
    Melo, Vinicio
    Nelemans, Levi Collin
    Vlaming, Martijn
    Lourens, Harm Jan
    Wiersma, Valerie R.
    Bilemjian, Vrouyr
    Huls, Gerwin
    de Bruyn, Marco
    Bremer, Edwin
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [43] Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
    Chang, Li-Sheng
    Leng, Chih-Hsiang
    Yeh, Yi-Chen
    Wu, Chiao-Chieh
    Chen, Hsin-Wei
    Huang, Hai-Mei
    Liu, Shih-Jen
    MOLECULAR CANCER, 2014, 13
  • [44] Toll-like receptor 9 agonist enhances anti-tumor immunity and inhibits tumor-associated immunosuppressive cells numbers in a mouse cervical cancer model following recombinant lipoprotein therapy
    Li-Sheng Chang
    Chih-Hsiang Leng
    Yi-Chen Yeh
    Chiao-Chieh Wu
    Hsin-Wei Chen
    Hai-Mei Huang
    Shih-Jen Liu
    Molecular Cancer, 13
  • [45] FOXF1 inhibits invasion and metastasis of lung adenocarcinoma cells and enhances anti-tumor immunity via MFAP4/FAK signal axis
    Wang, Zhenyu
    Xie, MengXia
    Jia, Zhongyue
    Tao, Ziwei
    Zhao, Ping
    Ying, Muying
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy
    Zhang, Jianpeng
    Sun, Lin
    Li, Weiqiang
    Wang, Yanyu
    Li, Xinzhen
    Liu, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 114
  • [47] RETRACTION: Overexpression of macrophage stimulating 1 enhances the anti-tumor effects of IL-24 in esophageal cancer via inhibiting ERK-Mfn2 signaling-dependent mitophagy
    Zhang, Jianpeng
    Sun, Lin
    Li, Weiqiang
    Wang, Yanyu
    Li, Xinzhen
    Liu, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 179
  • [48] Venom of the desert black snake Walterinnesia aegyptia enhances anti-tumor immunity via its beneficial modulatory effects on pro- and anti-tumorigenic inflammatory mediators in cultured colon cancer cells
    Daghestani, Maha H.
    Ambreen, Khushboo
    Hakami, Hana H.
    Omair, Mohammed A.
    Saleem, Abdulaziz M.
    Aleisa, Nadia A.
    AlNeghery, Lina M.
    Amin, Mohannad H.
    Alobaid, Hussah M.
    Omair, Maha A.
    Hassen, Lena M.
    TOXICOLOGY RESEARCH, 2021, 10 (06) : 1116 - 1128
  • [49] A cold-water extracted polysaccharide-protein complex from Grifola frondosa exhibited anti-tumor activity via TLR4-NF-xB signaling activation and gut microbiota modification in H22 tumor-bearing mice
    Zhao, Jiahui
    He, Rongjun
    Zhong, Hao
    Liu, Shizhu
    Liu, Xiaofeng
    Hussain, Muhammad
    Sun, Peilong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 239
  • [50] SEPT9_v2, frequently silenced by promoter hypermethylation, exerts anti-tumor functions through inactivation of Wnt/β-catenin signaling pathway via miR92b-3p/FZD10 in nasopharyngeal carcinoma cells
    Yu Jiang
    Lei Liu
    Qin Xiang
    Xiaoqian He
    Yan Wang
    Dishu Zhou
    Can Zou
    Qian Chen
    Mingyu Peng
    Jin He
    Xianyao Jiang
    Tingxiu Xiang
    Yucheng Yang
    Clinical Epigenetics, 2020, 12
12345